21 May 2019
By Dr Wendy Winnall - PCFA Research Team
Researchers have successfully made an antibody to target prostate cancer. This antibody binds a protein called PSMA, found on the surface of prostate cancer cells. It is a “biological tool”, with the potential to be part of a new therapy targeting prostate cancer. This week’s blog explains what an antibody is, and how they are revolutionising cancer therapies.
To read the full article just log into the PCFA Online Community.
If you're not already a member, it is free and easy to join.
